Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Case Report Volume 5 Issue 6

Can COVID-19 Cause Relapses in the Control of Epilepsy among Epileptic Patients Who were on Treatment and Controlled? A Case Report, Sudan, Khartoum, 2021

Amira Siddig1, Khabab Abbasher2*, Abbasher Hussien3, Mazin Salah-Eldien Hassan2, Ibrahim Mahgoub2, Hussien Abbasher4, Mohamed Abbasher5 and Radi Tofaha Alhusseini6

1Associated Professor of Community Medicine, Faculty of Medicine, Al Neelain University, Khartoum, Sudan
2MBBS Student, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
3Professor of Neurology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
4MBBS Student, Faculty of Medicine, Khartoum, Sudan
5MBBS Student, Faculty of Medicine, Al Neelain University, Khartoum, Sudan
6Faculty of Medicine, Alzaiem Alazhari University, Khartoum, Sudan

*Corresponding Author: Khabab Abbasher, MBBS Student, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.

Received: April 24, 2021; Published: May 11, 2021


Introduction: Corona viruses are a group of related viruses that cause diseases in mammals and birds. Epilepsy is one of the commonest neurological disorders. It is a clinical syndrome characterized by recurrent attacks of unprovoked seizures.

Case Presentation: A 45 years old Sudanese male who was diagnosed as a case of generalized tonic-clonic epilepsy in the last two years and used to take levetiracetam 1000mg bid. He was well controlled; the last attack was two years ago. He was brought to the casualty complaining of generalized tonic-clonic convulsions. The attack was so severe to a degree that it didn't respond to I.V diazepam; so he received I.V phenytoin and it didn't respond also. He received I.V levetiracetam, general anesthesia and then he was connected to a ventilator. His wife mentioned that he used to take his medication regularly and the condition was preceded by febrile illness, headache, sore throat and dry cough. A comprehensive and full neurological history and examination were done. Routine blood investigations were done including: complete blood count, random blood glucose, blood urea and creatinine, and radiological imaging including chest x-ray, brain MRI and EEG. Screening of COVID-19 was positive. This condition of COVID-19 on top of epilepsy caused induction of status-epilepticus attack that resulted in the death of the patient due to respiratory muscles paralysis.

Conclusion: COVID-19 can cause relapse in the control of well-controlled epileptic patients. Also it can cause status-epilepticus and increases resistance against anti-epileptic drugs during the attack of status-epilepticus causing prolongation of attack period and difficulty in management and control.

Keywords: Epilepsy; COVID-19 Case Reports; Status Epilepticus


  1. Colaneri M., et al. “Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020”. Euro Surveillance16 (2020).
  2. Elger CE and Schnmidt D. “Modern management of epilepsy: a practical approach”. Epilepsy and Behavior 12 (2008): 501-539.
  3. Shereen M., et al. “COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses”. Journal of Advanced Research 24 (2020): 91-98.
  4. Ali A Asadi-Pooya. “Seizures associated with coronavirus infections”. Seizure 79 (2020): 49-52.
  5. , et al. “New-onset acute symptomatic seizure and risk factors in Coronavirus disease 2019: A Retrospective multicenter study”. Epilepsia (2020): 118.
  6. Kuroda N. “Epilepsy and COVID-19: Associations and important5-5 considerations”. Epilepsy Behavior 108 (2020): 107122.
  7. Naoto Kuroda. “Epilepsy and COVID-19: Associations and important considerations”. Epilepsy Behavior (2020): 107122.
  8. Pan L., et al. “How to Face the Novel Coronavirus Infection During the 2019-2020 Epidemic: The Experience of Sichuan Provincial People’s Hospital”. Intensive Care Medicine 46 (2020): 573-575.


Citation: Khabab Abbasher., et al. “Can COVID-19 Cause Relapses in the Control of Epilepsy among Epileptic Patients Who were on Treatment and Controlled? A Case Report, Sudan, Khartoum, 2021”.Acta Scientific Medical Sciences 5.6 (2021): 39-41.


Copyright: © 2021 Khabab Abbasher., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US